NR 507 – Advanced Pathophysiology Midterm Practice Exam (Weeks 1–4)
NR 507
ADVANCED PATHOPHYSIOLOGY
Midterm Practice Exam Bank
Weeks 1–4 | Chamberlain University Style
This practice bank contains original multiple-choice questions with detailed rationales aligned to the common NR 507 midterm
blueprint (immunity/inflammation, hematology, cardiovascular, pulmonary, and basic renal pathophysiology).
Section Topics Questions
A Immunity, Inflammation, Hypersensitivity, Autoimmunity, HIV 1–25
B Hematology – Anemias, Sickle Cell, Coagulation Basics 26–45
C Cardiovascular – CAD, Heart Failure, Valves, Hypertension 46–65
D Pulmonary – Asthma, COPD, Obstructive vs Restrictive 66–80
E Renal / Urinary – UTI, AKI concepts, Basic Renal Patho 81–95
DISCLAIMER
This is an original study aid only. It is not an official Chamberlain University examination. Course content, exam blueprints, and question styles vary by term
and instructor. Use this material to reinforce understanding of advanced pathophysiology concepts. Always refer to your course syllabus, required textbook,
Edapt modules, and instructor guidance.
Page 1
,NR 507 – Advanced Pathophysiology Midterm Practice Exam (Weeks 1–4)
SECTION A — Immunity, Inflammation, Hypersensitivity & Autoimmunity (Q1–25)
1. Innate immunity is best characterized as:
A. Slow, highly specific, and capable of memory
B. Rapid, non-specific, and lacking immunologic memory
C. Dependent only on antibody production
D. Restricted to T-cell responses
Answer: B
Rationale: Innate immunity provides immediate defense (barriers, phagocytes, complement, NK cells) without prior sensitization or memory.
2. The primary antibody class produced during a primary (first) immune response is:
A. IgG
B. IgM
C. IgE
D. IgA
Answer: B
Rationale: IgM is the first immunoglobulin synthesized in a primary response; class switching later produces IgG and other isotypes.
3. Type I hypersensitivity is mediated primarily by:
A. IgG and complement
B. IgE bound to mast cells and basophils
C. Cytotoxic T cells
D. Immune-complex deposition
Answer: B
Rationale: Type I (immediate) reactions involve allergen-specific IgE on mast cells/basophils; cross-linking triggers degranulation and mediator
release.
4. Which of the following is a classic Type II hypersensitivity reaction?
A. Anaphylaxis to penicillin
B. Autoimmune hemolytic anemia or Goodpasture syndrome
C. Serum sickness
D. Tuberculin skin-test reaction
Answer: B
Rationale: Type II involves IgG/IgM antibodies directed against cell-surface or matrix antigens, causing cytotoxicity or dysfunction.
5. Type III hypersensitivity results from:
A. Direct T-cell cytotoxicity
B. Deposition of circulating immune complexes with complement activation
C. Only IgE-mediated mast-cell degranulation
D. Barrier defects alone
Answer: B
Rationale: Type III is driven by antigen-antibody complexes that deposit in tissues, activate complement, and recruit neutrophils (e.g., SLE
nephritis, serum sickness).
6. Type IV hypersensitivity is distinguished by:
A. Immediate onset and antibody mediation
B. Delayed onset (48–72 h) and T-cell mediation
C. Exclusive complement involvement
D. Purely anaphylactic features
Answer: B
Rationale: Type IV (delayed-type) hypersensitivity is cell-mediated by T lymphocytes and macrophages; examples include tuberculin reactivity
and contact dermatitis.
7. Systemic lupus erythematosus (SLE) is primarily an example of:
A. Type I hypersensitivity
B. Type III (immune-complex) disease with additional Type II features
C. Pure Type IV disease
D. Only innate immune dysfunction
Answer: B
Rationale: SLE involves formation and deposition of immune complexes (Type III) as well as autoantibodies against cell components (Type II
features).
Page 2
, NR 507 – Advanced Pathophysiology Midterm Practice Exam (Weeks 1–4)
8. The hallmark autoantibody most specific for SLE is:
A. Anti-CCP
B. Anti-dsDNA or anti-Smith (anti-Sm)
C. Anti-TSH receptor
D. Rheumatoid factor only
Answer: B
Rationale: Anti-dsDNA and anti-Sm antibodies have high specificity for SLE and are used in diagnosis and disease monitoring.
9. Primary (congenital) immunodeficiency differs from secondary immunodeficiency in that primary forms:
A. Are always acquired later in life
B. Result from intrinsic genetic or developmental defects in immune components
C. Are caused only by HIV
D. Never involve antibody defects
Answer: B
Rationale: Primary immunodeficiencies are intrinsic (genetic/developmental); secondary forms result from external factors (HIV, drugs,
malnutrition, etc.).
10. HIV primarily targets which cell population?
A. Neutrophils
B. CD4+ T-helper lymphocytes
C. Erythrocytes
D. Plasma cells exclusively
Answer: B
Rationale: HIV binds CD4 and co-receptors, infecting and depleting CD4+ T cells, which progressively impairs cell-mediated and humoral
immunity.
11. The clinical definition of AIDS includes:
A. Any positive HIV antibody test alone
B. HIV infection plus a CD4 count <200 cells/µL or an AIDS-defining opportunistic condition
C. Only elevated viral load without CD4 change
D. Presence of IgE antibodies
Answer: B
Rationale: AIDS is diagnosed when HIV infection is accompanied by severe CD4 depletion (<200) or specific opportunistic diseases.
12. Acute inflammation is dominated in the first hours by which leukocyte?
A. Lymphocyte
B. Neutrophil
C. Eosinophil
D. Plasma cell
Answer: B
Rationale: Neutrophils are the earliest and most numerous cells in acute inflammation.
13. The cardinal signs of acute inflammation include all of the following EXCEPT:
A. Rubor (redness)
B. Tumor (swelling)
C. Calor (heat)
D. Cyanosis
Answer: D
Rationale: Classic signs are rubor, tumor, calor, dolor (pain), and loss of function. Cyanosis is not a cardinal inflammatory sign.
14. Histamine contributes to acute inflammation by:
A. Causing vasoconstriction only
B. Increasing vascular permeability and causing vasodilation
C. Inhibiting leukocyte recruitment
D. Promoting only fibrosis
Answer: B
Rationale: Histamine (from mast cells/basophils) dilates arterioles and increases venular permeability, producing the early vascular phase of
inflammation.
Page 3
NR 507
ADVANCED PATHOPHYSIOLOGY
Midterm Practice Exam Bank
Weeks 1–4 | Chamberlain University Style
This practice bank contains original multiple-choice questions with detailed rationales aligned to the common NR 507 midterm
blueprint (immunity/inflammation, hematology, cardiovascular, pulmonary, and basic renal pathophysiology).
Section Topics Questions
A Immunity, Inflammation, Hypersensitivity, Autoimmunity, HIV 1–25
B Hematology – Anemias, Sickle Cell, Coagulation Basics 26–45
C Cardiovascular – CAD, Heart Failure, Valves, Hypertension 46–65
D Pulmonary – Asthma, COPD, Obstructive vs Restrictive 66–80
E Renal / Urinary – UTI, AKI concepts, Basic Renal Patho 81–95
DISCLAIMER
This is an original study aid only. It is not an official Chamberlain University examination. Course content, exam blueprints, and question styles vary by term
and instructor. Use this material to reinforce understanding of advanced pathophysiology concepts. Always refer to your course syllabus, required textbook,
Edapt modules, and instructor guidance.
Page 1
,NR 507 – Advanced Pathophysiology Midterm Practice Exam (Weeks 1–4)
SECTION A — Immunity, Inflammation, Hypersensitivity & Autoimmunity (Q1–25)
1. Innate immunity is best characterized as:
A. Slow, highly specific, and capable of memory
B. Rapid, non-specific, and lacking immunologic memory
C. Dependent only on antibody production
D. Restricted to T-cell responses
Answer: B
Rationale: Innate immunity provides immediate defense (barriers, phagocytes, complement, NK cells) without prior sensitization or memory.
2. The primary antibody class produced during a primary (first) immune response is:
A. IgG
B. IgM
C. IgE
D. IgA
Answer: B
Rationale: IgM is the first immunoglobulin synthesized in a primary response; class switching later produces IgG and other isotypes.
3. Type I hypersensitivity is mediated primarily by:
A. IgG and complement
B. IgE bound to mast cells and basophils
C. Cytotoxic T cells
D. Immune-complex deposition
Answer: B
Rationale: Type I (immediate) reactions involve allergen-specific IgE on mast cells/basophils; cross-linking triggers degranulation and mediator
release.
4. Which of the following is a classic Type II hypersensitivity reaction?
A. Anaphylaxis to penicillin
B. Autoimmune hemolytic anemia or Goodpasture syndrome
C. Serum sickness
D. Tuberculin skin-test reaction
Answer: B
Rationale: Type II involves IgG/IgM antibodies directed against cell-surface or matrix antigens, causing cytotoxicity or dysfunction.
5. Type III hypersensitivity results from:
A. Direct T-cell cytotoxicity
B. Deposition of circulating immune complexes with complement activation
C. Only IgE-mediated mast-cell degranulation
D. Barrier defects alone
Answer: B
Rationale: Type III is driven by antigen-antibody complexes that deposit in tissues, activate complement, and recruit neutrophils (e.g., SLE
nephritis, serum sickness).
6. Type IV hypersensitivity is distinguished by:
A. Immediate onset and antibody mediation
B. Delayed onset (48–72 h) and T-cell mediation
C. Exclusive complement involvement
D. Purely anaphylactic features
Answer: B
Rationale: Type IV (delayed-type) hypersensitivity is cell-mediated by T lymphocytes and macrophages; examples include tuberculin reactivity
and contact dermatitis.
7. Systemic lupus erythematosus (SLE) is primarily an example of:
A. Type I hypersensitivity
B. Type III (immune-complex) disease with additional Type II features
C. Pure Type IV disease
D. Only innate immune dysfunction
Answer: B
Rationale: SLE involves formation and deposition of immune complexes (Type III) as well as autoantibodies against cell components (Type II
features).
Page 2
, NR 507 – Advanced Pathophysiology Midterm Practice Exam (Weeks 1–4)
8. The hallmark autoantibody most specific for SLE is:
A. Anti-CCP
B. Anti-dsDNA or anti-Smith (anti-Sm)
C. Anti-TSH receptor
D. Rheumatoid factor only
Answer: B
Rationale: Anti-dsDNA and anti-Sm antibodies have high specificity for SLE and are used in diagnosis and disease monitoring.
9. Primary (congenital) immunodeficiency differs from secondary immunodeficiency in that primary forms:
A. Are always acquired later in life
B. Result from intrinsic genetic or developmental defects in immune components
C. Are caused only by HIV
D. Never involve antibody defects
Answer: B
Rationale: Primary immunodeficiencies are intrinsic (genetic/developmental); secondary forms result from external factors (HIV, drugs,
malnutrition, etc.).
10. HIV primarily targets which cell population?
A. Neutrophils
B. CD4+ T-helper lymphocytes
C. Erythrocytes
D. Plasma cells exclusively
Answer: B
Rationale: HIV binds CD4 and co-receptors, infecting and depleting CD4+ T cells, which progressively impairs cell-mediated and humoral
immunity.
11. The clinical definition of AIDS includes:
A. Any positive HIV antibody test alone
B. HIV infection plus a CD4 count <200 cells/µL or an AIDS-defining opportunistic condition
C. Only elevated viral load without CD4 change
D. Presence of IgE antibodies
Answer: B
Rationale: AIDS is diagnosed when HIV infection is accompanied by severe CD4 depletion (<200) or specific opportunistic diseases.
12. Acute inflammation is dominated in the first hours by which leukocyte?
A. Lymphocyte
B. Neutrophil
C. Eosinophil
D. Plasma cell
Answer: B
Rationale: Neutrophils are the earliest and most numerous cells in acute inflammation.
13. The cardinal signs of acute inflammation include all of the following EXCEPT:
A. Rubor (redness)
B. Tumor (swelling)
C. Calor (heat)
D. Cyanosis
Answer: D
Rationale: Classic signs are rubor, tumor, calor, dolor (pain), and loss of function. Cyanosis is not a cardinal inflammatory sign.
14. Histamine contributes to acute inflammation by:
A. Causing vasoconstriction only
B. Increasing vascular permeability and causing vasodilation
C. Inhibiting leukocyte recruitment
D. Promoting only fibrosis
Answer: B
Rationale: Histamine (from mast cells/basophils) dilates arterioles and increases venular permeability, producing the early vascular phase of
inflammation.
Page 3